These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias. Lindeboom SF; Lakke JP Acta Neurol Scand; 1978 Aug; 58(2):134-8. PubMed ID: 360761 [TBL] [Abstract][Full Text] [Related]
27. Deanol in the treatment of tardive dyskinesia. Casey DE; Denny D Am J Psychiatry; 1975 Aug; 132(8):864-7. PubMed ID: 1147074 [TBL] [Abstract][Full Text] [Related]
28. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Re' O Curr Ther Res Clin Exp; 1974 Nov; 16(11):1238-42. PubMed ID: 4279161 [No Abstract] [Full Text] [Related]
29. Letter: Deanol for tardive dyskinesia. Casey DE N Engl J Med; 1975 Aug; 293(7):359. PubMed ID: 1152930 [No Abstract] [Full Text] [Related]
30. Deanol in tardive dyskinesia: a preliminary report. Fann WE; Sullivan JL; Miller RD; McKenzie GM Psychopharmacologia; 1975 May; 42(2):135-7. PubMed ID: 1161974 [No Abstract] [Full Text] [Related]
31. Letter: Deanol: a solution for tardive dyskinesia? Miller EM N Engl J Med; 1974 Oct; 291(15):796-7. PubMed ID: 4414178 [No Abstract] [Full Text] [Related]
32. Deanol in tardive dyskinesia. De Silva L; Huang CY Br Med J; 1975 Aug; 3(5981):466. PubMed ID: 1156821 [No Abstract] [Full Text] [Related]
33. Tardive dyskinesia: are there subtypes? Casey DE N Engl J Med; 1976 Nov; 295(19):1078. PubMed ID: 972665 [No Abstract] [Full Text] [Related]